# Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus

> **NCT05413005** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Abu Dhabi Stem Cells Center** · enrollment: 10 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **COMBINATION_PRODUCT:** ECP regular-intensity arm
- **COMBINATION_PRODUCT:** ECP accelerated-intensity arm
- **BIOLOGICAL:** T1DM standard of care

## Key facts

- **NCT ID:** NCT05413005
- **Lead sponsor:** Abu Dhabi Stem Cells Center
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-09-05
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05413005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05413005, "Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT05413005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*